Fibromyalgia patients frequently suffer from symptoms similar to those of adult celiac disease, raising the possibility that some fibromyalgia patients experience oligosymptomatic celiac disease or non-celiac gluten intolerance. The objective of this study is to compare the effect of a gluten-free diet with a hypocaloric diet in patients with fibromyalgia and celiac-type symptoms.
Fibromyalgia, a chronic pain disorder, is characterized by generalized chronic musculoskeletal pain that is usually accompanied by several other clinical manifestations that contribute to a diminished quality of life, such as sleep disturbances, chronic fatigue, mood disorders, and cognitive difficulties. Many patients with fibromyalgia suffer from gastrointestinal and extra-intestinal symptoms that are similar to those experienced by adult celiac disease patients such as abdominal pain, dyspepsia, nausea, diarrhea, constipation, fatigue, pain and mood changes. This raises the possibility that some patients with fibromyalgia may also suffer from oligosymptomatic celiac disease or non-celiac gluten intolerance. On the other hand, the emerging evidence linking obesity with fibromyalgia and the high prevalence of overweight among fibromyalgia patients suggest a potential benefit for weight loss among these patients. Thus, the main objective of this study is to compare the efficacy of a gluten-free diet (GFD) with a hypocaloric diet (HCD) in patients with fibromyalgia that also experience celiac-type symptoms.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
81
A diet that is free of the gluten component
A standard hypocaloric diet with a daily 1500 caloric intake.
Instituto de Neurociencias "Federico Oloriz"
Granada, Granada, Spain
Change, between baseline and endpoint, in the number of experienced celiac-type symptoms
Time frame: 0, 4, 8, 12, 18 and 24 weeks
Change, between baseline and endpoint, in the Body Mass Index
Time frame: 0, 4, 8, 12, 18 and 24 weeks
Change, between baseline and endpoint, in the Revised Fibromyalgia Impact Questionnaire total score
Time frame: 0, 4, 8, 12, 18 and 24 weeks
Change, between baseline and endpoint, in the Pittsburgh Sleep Quality Index
Time frame: 0, 4, 8, 12, 18 and 24 weeks
Change, between baseline and endpoint, in the Brief Pain Inventory
Time frame: 0, 4, 8, 12, 18 and 24 weeks
Change, between baseline and endpoint, in the Beck Depression Inventory
Time frame: 0, 4, 8, 12, 18 and 24 weeks
Change, between baseline and endpoint, in the Short-form Health Survey
Time frame: 0, 4, 8, 12, 18 and 24 weeks
Change, between baseline and endpoint, in the State-Trait Anxiety Inventory
Time frame: 0, 4, 8, 12, 18, 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.